119 related articles for article (PubMed ID: 8881374)
1. Triazolines 26: 1-Aryl-5-amido-1,2,3-triazolines, a new group of triazoline anticonvulsants. Effect of 5-substitution on anticonvulsant activity.
Kadaba PK
Biomed Pharmacother; 1996; 50(3-4):163-9. PubMed ID: 8881374
[TBL] [Abstract][Full Text] [Related]
2. Triazolines. 14. 1,2,3-Triazolines and triazoles, a new class of anticonvulsants. Drug design and structure-activity relationships.
Kadaba PK
J Med Chem; 1988 Jan; 31(1):196-203. PubMed ID: 3336019
[TBL] [Abstract][Full Text] [Related]
3. Triazolines--XXVII. delta2-1,2,3-triazoline anticonvulsants: novel 'built-in' heterocyclic prodrugs with a unique 'dual-action' mechanism for impairing excitatory amino acid L-glutamate neurotransmission.
Kadaba PK; Stevenson PJ; P-Nnane I; Damani LA
Bioorg Med Chem; 1996 Feb; 4(2):165-78. PubMed ID: 8814876
[TBL] [Abstract][Full Text] [Related]
4. Rational drug design and the discovery of the delta2-1,2,3-triazolines, a unique class of anticonvulsant and antiischemic agents.
Kadaba PK
Curr Med Chem; 2003 Oct; 10(20):2081-108. PubMed ID: 12871087
[TBL] [Abstract][Full Text] [Related]
5. Triazolines XIII: delta 2-1,2,3-triazolines, a new class of anticonvulsants.
Kadaba PK
J Pharm Sci; 1984 Jun; 73(6):850-2. PubMed ID: 6737279
[TBL] [Abstract][Full Text] [Related]
6. Triazolines XV. Anticonvulsant profile of ADD 17014, a potentially unique 1,2,3-triazoline antiepileptic drug, in mice and rats.
Kadaba PK; Slevin JT
Epilepsia; 1988; 29(3):330-7. PubMed ID: 3371287
[TBL] [Abstract][Full Text] [Related]
7. N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA(A) receptor sharing electrophysiological properties with the anticonvulsant loreclezole.
El Hadri A; Abouabdellah A; Thomet U; Baur R; Furtmüller R; Sigel E; Sieghart W; Dodd RH
J Med Chem; 2002 Jun; 45(13):2824-31. PubMed ID: 12061884
[TBL] [Abstract][Full Text] [Related]
8. Triazolines. 34. Structure and stability relationships of novel delta 2-1,2,3-triazoline anticonvulsants.
Chow AH; Chiu FC; Damani LA; Kadaba PK
Pharm Res; 1996 Jan; 13(1):179-82. PubMed ID: 8668671
[No Abstract] [Full Text] [Related]
9. Triazolines. XXII. Chromatography of 1-phenyl-5-(4-pyridyl)-delta 2-1,2,3-triazolines and related 1,2,3-triazoles, a new class of anticonvulsant agents.
Stevenson PJ; Hauksdottir R; Kadaba PK; Damani LA
J Chromatogr; 1990 Nov; 533():248-54. PubMed ID: 2081772
[No Abstract] [Full Text] [Related]
10. Aminoalkylpyridines (AAPs), triazoline metabolite analogues, as anticonvulsants highly effective in the MES test.
Kadaba PK; Dixit T
Curr Med Chem; 2003 Oct; 10(20):2109-21. PubMed ID: 12871088
[TBL] [Abstract][Full Text] [Related]
11. Triazolines. XXI: Preformulation degradation kinetics and chemical stability of a novel triazoline anticonvulsant.
Freeke Hamelijnck MA; Stevenson PJ; Kadaba PK; Damani LA
J Pharm Sci; 1992 Apr; 81(4):392-6. PubMed ID: 1501079
[TBL] [Abstract][Full Text] [Related]
12. Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system.
Plech T; Kaproń B; Luszczki JJ; Paneth A; Siwek A; Kołaczkowski M; Żołnierek M; Nowak G
Eur J Med Chem; 2014 Oct; 86():690-9. PubMed ID: 25226229
[TBL] [Abstract][Full Text] [Related]
13. 5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents.
Kane JM; Staeger MA; Dalton CR; Miller FP; Dudley MW; Ogden AM; Kehne JH; Ketteler HJ; McCloskey TC; Senyah Y
J Med Chem; 1994 Jan; 37(1):125-32. PubMed ID: 8289185
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 1-phenyl-1H-1,2,3-triazoles as selective insect GABA receptor antagonists.
Alam MS; Kajiki R; Hanatani H; Kong X; Ozoe F; Matsui Y; Matsumura F; Ozoe Y
J Agric Food Chem; 2006 Feb; 54(4):1361-72. PubMed ID: 16478261
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted-thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives.
Gülerman N; Rollas S; Kiraz M; Ekinci AC; Vidin A
Farmaco; 1997 Nov; 52(11):691-5. PubMed ID: 9550096
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsants containing the N-(3-aryl-2-propenoyl) amido pharmacophore.
Dimmock JR; Gunda SG; Vashishtha SC; Zello GA; Das U; Nienaber KH; Stables JP; Allen TM; Santos CL
J Enzyme Inhib Med Chem; 2004 Aug; 19(4):303-12. PubMed ID: 15558945
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticonvulsant activity of some new 1,1-bis(4-substituted 1,2,4-triazoline-5-thione-3-yl)-2-methylbutanes.
Ergenç N; Ulusoy N; Ekinci AC
Farmaco; 1995 Mar; 50(3):189-92. PubMed ID: 7755867
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels.
Kombian SB; Edafiogho IO; Ananthalakshmi KV
Br J Pharmacol; 2005 Aug; 145(7):945-53. PubMed ID: 15912138
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of R-[3H]-baclofen binding to rat brain synaptic membranes by a homologous series of phenyl alcohol amides anticonvulsants and their evaluation as GABAB receptor blockers.
Meza-Toledo SE; Martínez-Muñoz D; Carvajal-Sandoval G
Arzneimittelforschung; 1998 Nov; 48(11):1051-7. PubMed ID: 9850423
[TBL] [Abstract][Full Text] [Related]
20. Investigation into new anticonvulsant derivatives of alpha-substituted N-benzylamides of gamma-hydroxy- and gamma-acetoxybutyric acid. Part 5: search for new anticonvulsant compounds.
Malawska B; Kulig K; Spiewak A; Stables JP
Bioorg Med Chem; 2004 Feb; 12(3):625-32. PubMed ID: 14738973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
